– Company Anticipates Investigational New Drug Applications for Nine or More Programs with Targets Expressed in the Liver, Central Nervous System, Adipose Tissue, and Muscle by End of 2025.
Alnylam Pharma (ALNY) Highlights Significant Progress with Platform Innovation and Clinical Pipeline streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Direct News Source
CALC (1848.HK) announces 2020 annual results Identifying opportunities in a crisis while persisting in the strategy of ploughing deep into the Chinese market
China Aircraft Leasing Group Holdings Limited ( CALC or the “Company”, HKSE stock code: 01848; together with subsidiaries, the “Group”), a full value chain aircraft solutions provider for the global aviation industry, is pleased to announce the Group’s results for the year ended 31 December 2020 (the “Review Year”).
Financial Highlights
CALC navigated its journey through an extremely challenging year in 2020. During the Review Year, total revenue of the Group amounted to HK$3,485.8 million (2019: HK$3,523.2 million). Operating profit was approximately HK$948.7 million (2019: HK$967.6 million). Both were maintained at similar levels to those of last year.